(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.

GUEST:
HEALTHCARE: John Crowley, CEO of Amicus Therapeutics, on expanding its pipeline of treatments for rare and orphan diseases.
 Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: HEALTHCARE: John Crowley, CEO of Amicus Therapeutics, on expanding its pipeline of treatments for rare and orphan diseases. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Amicus' Crowley on Expanding Pipeline for Rare Diseases (Audio)

Matt Miller and Paul Sweeney focus on market coverage as Wall Street begins its day, with analysis from Bloomberg Opinion writers, Bloomberg Intelligence analysts, and influential newsmakers.

Share Amicus' Crowley on Expanding Pipeline for Rare Diseases (Audio)

Sign up to save your podcasts

Amicus' Crowley on Expanding Pipeline for Rare Diseases (Audio)

Amicus' Crowley on Expanding Pipeline for Rare Diseases (Audio)